))
A Discussion with Brian Finn of Findell Capital: Biotech Investing, Liquidia & ProQR
Manage episode 337249290 series 3380517
Content provided by Encode Ideas, L.P., Encode Ideas, and L.P.. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Encode Ideas, L.P., Encode Ideas, and L.P. or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
An interview with Brian Finn of Findell Capital, where we discuss his perspective on small-cap investing. During the interview, we discuss two of Brian's favorite health care names, Liquidia and ProQR, as well as his previous success with MiMedx. To learn more about Findell Capital please visit their website https://findell.us/
Companies discussed during the podcast;
- Liquidia Corporation (Nasdaq: LQDA)
- ProQR Therapeutics N.V. (Nasdaq: PRQR)
- MiMedx Group Inc (Nasdaq: MDXG)
- United Therapeutics Corporation (Nasdaq: UTHR)
- MannKind Corporation (Nasdaq: MNKD)
- Editas Medicine Inc (Nasdaq: EDIT)
7 episodes
Share
